Abstract:Aberrant expression of microRNAs (miRNAs or miRs) is associated with a number of human diseases, including lung cancer. Although numerous differentially expressed miRNAs have been identified in lung cancer via microarray and sequencing methods, to the best of our knowledge, only a small portion of these miRNAs have been experimentally verified. In the present study, miR-1301-3p expression levels in lung tumor tissues and lung cancer cells were measured by reverse transcription-quantitative PCR (RT-qPCR) and by analyzing previously published data. Cell Counting Kit-8 and Transwell assays were used to analyze the function of miR-1301-3p in lung cancer tissues and cells. Bioinformatics analysis, RT-qPCR, western blotting and a dual-luciferase reporter assay were performed to investigate the mechanism of miR-1301-3p in lung cancer cells. It was identified that miR-1301-3p is an upregulated miRNA in lung cancer via analyzing previously published microarray and The Cancer Genome Atlas-lung squamous cell carcinoma project data, and the upregulation of miR-1301-3p was confirmed in collected clinical samples and cells. Inhibition of miR-1301-3p suppressed lung cancer cell proliferation and migration. In addition, miR-1301-3p inhibition upregulated E-cadherin, an epithelial cell maker, and downregulated vimentin, a mesenchymal cell marker. Using bioinformatics analysis, it was revealed that polymerase I and transcript release factor (PTRF) is a target of miR-1301-3p. RT-qPCR, western blotting and dual-luciferase reporter assays demonstrated that PTRF is targeted by miR-1301-3p in lung cancer cells. The rescue experiments indicated that silencing PTRF could attenuate the inhibition of cell proliferation and migration induced by miR-1301-3p inhibitor in lung cancer cells. Furthermore, a strong negative correlation between miR-1301-3p and PTRF mRNA was identified in clinical samples. In summary, the present data highlight the involvement of miR-1301-3p in the proliferation and migration of lung cancer cells, indicating that miR-1301-3p may be a promising biomarker for lung cancer.

Mir-1306 Promotes Lung Squamous Cell Carcinoma Progression and Predicts Clinical Prognosis of Patients.

Identification Of Mir-133a-3p-Expression Signature And Probable Mechanism In Lung Squamous Cell Carcinoma: Insights From Integrated Analysis

Long noncoding RNA CASC15 is upregulated in non-small cell lung cancer and facilitates cell proliferation and metastasis via targeting miR-130b-3p.

Up-Regulation Of Mir-182-5p Predicts Poor Prognosis In Patients With Lung Cancer And Associates With Tumor Cell Growth And Migration

Mir-1225-5p Inhibits Non-Small Cell Lung Cancer Cell Proliferation, Migration and Invasion, and May Be a Prognostic Biomarker.

Mir-1246 Promotes Laryngeal Squamous Cell Carcinoma Progression by Interacting with THBS1.

Expression of lncRNA LINC00943 in lung squamous cell carcinoma and its relationship with tumor progression

Mir-1301-3p Promotes the Proliferation and Migration of Lung Cancer Cells Via Direct Repression of Polymerase I and Transcript Release Factor.

Investigation of Mir-136-5p Key Target Genes and Pathways in Lung Squamous Cell Cancer Based on TCGA Database and Bioinformatics Analysis

Clinical Significance of High Expression of Mir-452-5p in Lung Squamous Cell Carcinoma.

Mir-550A-5p Functions As a Tumor Promoter by Targeting LIMD1 in Lung Adenocarcinoma

Clinical Value and Potential Mechanism of Mirna-33A-5p in Lung Squamous Cell Carcinoma

A novel microRNA panel exhibited significant potential in evaluating the progression of laryngeal squamous cell carcinoma

Gene Regulation and Prognostic Indicators of Lung Squamous Cell Carcinoma: TCGA-derived Mirna/mrna Sequencing and DNA Methylation Data.

Downregulation of Mir-125B-5p and Its Prospective Molecular Mechanism in Lung Squamous Cell Carcinoma.

Downregulation of miRNA-126-3p is associated with progression of and poor prognosis for lung squamous cell carcinoma

Expression of Oncogenic Long Noncoding RNA PSMG3-antisense 1 in Lung Squamous Cell Carcinoma

Machine Learning Identifies 10 Feature Mirnas for Lung Squamous Cell Carcinoma.

Clinical Value of Mir-182-5p in Lung Squamous Cell Carcinoma: a Study Combining Data from TCGA, GEO, and RT-qPCR Validation

MiR-937-3p Promotes Metastasis and Angiogenesis and is Activated by MYC in Lung Adenocarcinoma

Identification of Mir-130B As an Oncogene in Renal Cell Carcinoma